h 1356 has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
| Studies (h 1356) | Trials (h 1356) | Recent Studies (post-2010) (h 1356) | Studies (1-methyl-4-phenylpyridinium) | Trials (1-methyl-4-phenylpyridinium) | Recent Studies (post-2010) (1-methyl-4-phenylpyridinium) |
|---|---|---|---|---|---|
| 15 | 0 | 9 | 1,854 | 1 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WF; Chen, XH; Jiang, MC; Zhang, XJ; Zhao, X | 1 |
1 other study(ies) available for h 1356 and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Involvement of IGF-1 receptor signaling pathway in the neuroprotective effects of Icaritin against MPP(+)-induced toxicity in MES23.5 cells.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Cell Line; Chromones; Flavonoids; Gene Expression Regulation, Enzymologic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Neurons; Neuroprotective Agents; Oligopeptides; Organic Chemicals; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Signal Transduction | 2016 |